| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.37 | 3e-11 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.36 | 2e-10 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 7e-09 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.24 | 1e-08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.37 | 3e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.19 | 6e-07 |